Sign up to save your podcasts
Or
Share Lowering hematocrit below 45 per cent protects against clotting risk in patients with polycythemia vera — randomized study finding
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Lowering hematocrit below 45 per cent protects against clotting risk in patients with polycythemia vera — randomized study finding
ATLANTA, GA—Solid confirmation of target hematocrit to minimise clotting risks in polycythemia vera has been presented at the American Society of Hematology annual meeting and simultaneously published in the…
View all episodes
By AudioMedica.comATLANTA, GA—Solid confirmation of target hematocrit to minimise clotting risks in polycythemia vera has been presented at the American Society of Hematology annual meeting and simultaneously published in the…